[HTML][HTML] Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002

EW Tiemersma, SLAM Bronzwaer… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
We explored the variation in proportions of methicillin-resistant Staphylococcus aureus
(MRSA) between and within countries participating in the European Antimicrobial …

Heart failure following STEMI: a contemporary cohort study of incidence and prognostic factors

JMIH Gho, PG Postema, M Conijn, N Bruinsma… - Open …, 2017 - openheart.bmj.com
Objective The aim of the current study was to determine the contemporary incidence, risk
factors and prognosis of heart failure (HF) after ST-elevation myocardial infarction (STEMI) …

Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe

N Bruinsma, KG Kristinsson… - Journal of …, 2004 - academic.oup.com
Objectives: To forecast trends in resistance to penicillin and erythromycin among
Streptococcus pneumoniae in Europe. Methods: Since 1999, the European Antimicrobial …

[HTML][HTML] Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000–2015

HF Sati, N Bruinsma, M Galas, J Hsieh, A Sanhueza… - PloS one, 2019 - journals.plos.org
Background Shigellosis is the second leading cause of diarrheal death globally. The global
burden has been complicated by the emergence of Shigella strains resistant to first line …

Different Levels of Genetic Homogeneity in Vancomycin-Resistant and -Susceptible Enterococcus faecium Isolates from Different Human and Animal Sources …

N Bruinsma, RJL Willems… - Antimicrobial agents …, 2002 - Am Soc Microbiol
The genetic relationship among fecal vancomycin-resistant Enterococcus faecium (VREF)
and vancomycin-susceptible E. faecium (VSEF) isolates (n= 178) from the same populations …

[HTML][HTML] Driving multisectoral antimicrobial resistance action in South America: Lessons learned from implementing an enhanced tripartite AMR country self …

N El Omeiri, A Beith, N Bruinsma, M Caipo, L Barcos… - One Health, 2023 - Elsevier
As part of an innovative Tripartite-EU collaboration Project that supports seven South
American countries, a Landscape Analysis Tool (LAT) was developed and implemented to …

[HTML][HTML] Staphylococcus aureus bacteremia, Europe

EW Tiemersma, DL Monnet, N Bruinsma… - Emerging Infectious …, 2005 - ncbi.nlm.nih.gov
In 2003, through a questionnaire, we collected background information on all hospitals
served by laboratories participating in EARSS, including the estimated hospitals' catchment …

[HTML][HTML] Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort …

M Van Barreveld, MGW Dijkgraaf, M Hulleman… - Netherlands Heart …, 2017 - Springer
Abstract Background Implantable cardioverter-defibrillators (ICDs) are widely used for the
prevention of sudden cardiac death. At present, both clinical benefit and cost-effectiveness …

Mild-to-moderate kidney dysfunction and the risk of sudden cardiac death in the setting of acute myocardial infarction

D Dalal, JSSG De Jong, FVY Tjong, Y Wang… - Heart rhythm, 2012 - Elsevier
BACKGROUND: Although end-stage renal disease is known to elevate the risk of sudden
cardiac death (SCD), the role of less severe renal impairment in SCD is unclear …

[HTML][HTML] SNPs identified as modulators of ECG traits in the general population do not markedly affect ECG traits during acute myocardial infarction nor ventricular …

R Pazoki, JSSG de Jong, RF Marsman, N Bruinsma… - PloS one, 2013 - journals.plos.org
Background Ventricular fibrillation (VF) in the setting of acute ST elevation myocardial
infarction (STEMI) is a leading cause of mortality. Although the risk of VF has a genetic …